Share Price:

APNASPENAspen Pharmacare Hldgs9769-43 (-0.44%)

Aspen concludes agreement to manufacture and make available an Aspen-branded COVID-19 vaccine (Aspenovax) throughout Africa

Stephen Saad, Aspen Group Chief Executive

โ€œWith the conclusion of this agreement, our vision for Africaโ€™s own vaccine has become a reality,โ€ said Stephen Saad, Aspen Group Chief Executive.

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.